In this update video blog on treating systemic lupus erythematosus, Stephen Paget, MD, highlights issues surrounding current clinical trials and present a personal approach to treatment. Medscape Rheumatology
This study examined patients with hip pain to determine their disease
progression and how many subsequently underwent total hip replacement Arthritis Care Research News Alerts
A patient with rheumatoid arthritis on methotrexate (MTX) is scheduled for surgery; should MTX be discontinued, and if so, for how long? Medscape Rheumatology
Ambrisentan, a diphenyl propionic acid derivative, represents a valuable addition to the treatment alternatives for this orphan disease AccessMedicine from McGraw-Hill
The objective of this study was to assess whether administration of alendronate (70 mg weekly) would prevent bone loss associated with tamoxifen discontinuation. Endocrine Practice
The metabolic syndrome is a cluster of cardiovascular risk factors that are of metabolic origin, and include atherogenic dyslipidemia, hypertension, and hyperglycemia. In RA patients, several other factors increase the risk of developing the syndrome. Future Rheumatology
